Summary Epidermal tumourigenesis can be achieved in rodents by the application of a single subthreshold dose of a carcinogen (initiation) followed by repeated applications of a tumour promoter such as 12-0-tetradecanoyl phorbol, 13-acetate (TPA). TPA induces terminal differentiation in the majority of epidermal keratinocytes in vitro. However, transformed keratinocytes respond weakly to this terminal differentiation signal, and it is suggested that this property allows initiated cells and their progeny to obtain a selective advantage over their normal counterparts during promotion of papilloma formation by TPA.
The two stage (initiation-promotion) system of epidermal tumourigenesis is achieved by a single application of a subthreshold (initiating) dose of a carcinogen (usually DMBA) followed by repeated applications of a tumour promoter such as 12-0-tetradecanoyl phorbol, 13-acetate (TPA). This method of inducing epidermal tumours has been reviewed many times (see Boutwell 1964; Stenback et al., 1974; Scribner & Suss 1978; Boutwell et al., 1982) and is applicable to many strains of mice (Di Giovanni et al., 1984 , and references therein), Sprague-Dawley rats (Schweizer et al., 1982) and European hamsters (Goerttler et al., 1984) .
How TPA and other manipulations of the skin such as wounding (Hennings & Boutwell 1970; Clark-Lewis & Murray, 1978) or deep epidermal abrasion (Argyris 1980a) promote the growth of an initiated cell into a tumour has until recently remained obscure. The purpose of this review is to evaluate evidence supporting the suggestion that TPA stimulates the development of tumours by selecting for keratinocytes which have acquired a reduced response to terminal differentiation signals as a result of initiation (Yuspa & Morgan, 1981) . The application of this selection hypothesis to other promoting stimuli, particularly physical injury will also be discussed.
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Two-stage epidermal tumourigenesis
The initiation-promotion protocol produces primarily clonal benign papillomas (Iannacone et al., 1978; Reddy & Fialkow, 1983) , the majority of which are promoter-dependent lesions, (i.e. their growth is reversible) although the probability that the papillomas will become autonomously growing and develop into carcinomas increases with the duration of promoter treatment (Burns et al., 1978; Verma & Boutwell, 1980) . TPA itself does not detectably increase the conversion rate of papillomas into carcinomas (Burns et al., 1978; Verma & Boutwell, 1980; Hennings et al., 1983) and at certain doses actually decreases it (Verma & Boutwell, 1980) . The inability of TPA to enhance malignant conversion may be related to its inactivity as a mutagen in mammalian cells (Trosko et al., 1977) since Hennings et al. (1983) have shown that carcinomatous transformation is enhanced by initiators suggesting that further gene mutations are required to complete carcinogenesis.
By the use of croton oil as a first stage promoter and turpentine as a second stage promoter, Boutwell (1964) was able to subdivide the promotion phase, and he termed the two stages conversion and propagation, respectively. Unfortunately, probably because of the inconsistent composition of turpentine preparations these results were not readily reproducible (Raick, 1974; Slaga et ©) The Macmillan Press Ltd., 1985 . However, in the last few years the use of TPA as a stage I promoter and mezerein (Slaga et al., 1980a, b) or 12-0-retinoylphorbol-13 acetate (RPA-Furstenberger et al., 1981; as the stage II promoter, it has been possible to demonstrate two qualitatively different stages of promotion using pure compounds. Stage I can be achieved by as little as one treatment with TPA (Slaga et al., 1980b; Furstenberger et al., 1983) and is longer lasting than stage II which requires multiple treatments before the papillomas appear.
2. The genetic and phenotypic nature of the initiation event Provided that appropriate corrections are made for mouse ageing, the initiation event can be demonstrated to be irreversible for at least a year (Van Duuren et al., 1975; Loehrke et al., 1983) suggesting that initiation involves a permanent change in the keratinocyte genome. Also since treatments of the epidermis which increase keratinocyte division in the absence of damage (e.g. skin massage) do not cause papilloma development in initiated skin (Clark-Lewis & Murray, 1978; Marks et al., 1979 ) the initiation event is generally held to be phenotypically silent (Boutwell, 1974; Boutwell et al., 1982) . However, there is evidence that if the gap between initiation and the beginning of promotion is increased from the usual two weeks to 10-40 weeks, the latent period between the commencement of promotion and the appearance of the first papillomas is reduced (Berenblum & Shubik, 1947 , Boutwell, 1964 Hennings & Boutwell, 1967; Van Duuren et al., 1967 Loehrke et al., 1983) , and this could indicate that the initiated cells are capable of limited clonal expansion without promoter treatment (see Hennings and Yuspa, 1985) .
Recent experiments by Yuspa and Morgan (1981) have shed some light on the possible phenotype of the initiated cell. In these experiments mouse skin was initiated in vivo and after 2 weeks the keratinocytes were placed in culture in medium containing low (< 0.1 mM) calcium where the cells maintain basal cell characteristics (Hennings et al., 1980 ) and remain as a monolayer. When these cultures were switched to medium containing high calcium (1.2mM) after an expression time of 11 weeks, the normal keratinocytes stratified, differentiated and sloughed from the dish, and staining of the plates revealed foci of keratinocytes resistant to calciuminduced terminal differentiation only in cultures prepared from initiated animals (Yuspa & Morgan, 1981) . Furthermore, TPA treatment of the initiated mice prior to placing the keratinocytes in culture resulted in an increase in the number of plates containing foci, significantly demonstrating that TPA had given the differentiation -resistant keratinocytes a selective advantage over their normal counterparts in vivo, an observation which is consistent with their being progeny of the initiated cells.
Even more recently, a candidate for the genomic target in keratinocyte initiation has emerged following the reports by Balmain and co-workers that genes related to the Harvey Murine Sarcoma Virus capable of transforming NIH 3T3 cells (rasH) can be rescued from both carcinomas (Balmain & Pragnell, 1983) and papillomas (Balmain et al., 1984) generated by the two stage protocol. Several of these 'activated' ras1 genes have been analysed and found to have mutations in either codon 12 or codon 61, furthermore the resulting mutant proteins can be distinguished from the normal rasH gene product by polyacrylamide gel electrophoresis (Balmain, 1985) . Additionally, Balmain and coworkers have shown that rasH delivered in its viral vector can mimic initiation in vivo, as no papillomas appear after infection of mouse skin with the Harvey Murine Sarcoma Virus alone but do so when TPA is repetitively applied (A. Balmainpersonal communication).
In vitro, ras-containing viruses can block keratinocyte differentiation at an early stage of maturation (Yuspa et al., 1983a; but the cells cannot proliferate very well when a differentiation stimulus is applied in the absence of TPA (Yuspa et al., 1985) . When TPA is applied proliferation results and Yuspa et al. (1985) interpret these findings as indicating that rasH activation could initiate the keratinocytes in vivo as the virusinfected cells do not grow well in the absence of TPA (a characteristic of promoter-dependent papillomas).
These two latter studies suggest that although other oncogenes may sometimes be involved, alteration of the rasH gene is capable of initiating mouse epidermal carcinogenesis. However, both studies used rasH delivered in the viral vector, which unlike the activated genes found in epidermal tumours (Balmain & Pragnell, 1983; Balmain et al., 1984) differs from the normal cellular homologue in more than one transforming codon and is also preceded by a long terminal repeat sequence which may increase gene expression (see Duesberg, 1983 , for a review). Therefore, keratinocytes infected with Harvey Murine Sarcoma Virus might reflect the behaviour of keratinocytes at a later stage of neoplastic progression which have acquired other modifications of the rasH gene beyond those required for the initiation step. Indeed, Spandidos and Wilkie (1984) (Argyris, 1980b; Reiners & Slaga, 1983) . In some cases the epidermis may become separated from the dermis (Argyris, 1980b) and psoriasis-like scaling of the skin sometimes occurs (Furstenberger et al., 1985) . The changes are the likely result of the ability of TPA to induce terminal differentiation in the majority of epidermal keratinocytes (Steinert & Yuspa, 1978; Yuspa et al., 1980; HawleyNelson et al., 1982; Parkinson & Emmerson, 1982; Mufson et al., 1982; Reiners & Slaga, 1983) . The loss of basal cells is followed by a peak of DNA synthesis at 30 h (Kreig et al., 1974) and a peak of mitosis at 2 days (Argyris, 1980b) . The increased rates of division are achieved by a reduction in the cell cycle time of the growth fraction from between 5 and 7 days before TPA treatment to -16 h at the peak of TPA induced proliferation. The increased rate of cell division is accompanied by a reduction in the epidermal transit time from 8 days before TPA treatment to 2 days at the peak of stimulation (Morris & Argyris, 1983) . At some stage cell production must temporarily exceed cell loss so that in combination with the above changes a thickening of all the epidermal layers is produced (hyperplasia), and the kinetic data suggest that it is largely the result of extensive tissue regeneration similar to that which follows epidermal damage (Argyris, 1980a, b) .
As most tumour promoters are hyperplasiogenic (Frei & Stephens, 1968) hyperplasia would appear to be crucial for tumour promotion. This is further supported by the study of TPA-induced promotion in different species displaying varying hyperplasia after repeated TPA treatments, where there was generally a good correlation between the ability of TPA to promote tumours and its ability to produce a sustained epidermal hyperplasia (Sisskin & Barrett, 1981; Sisskin et al., 1982) . The exception was the DBA/2 mouse strain which responded to TPA with a good sustained hyperplasia and a low tumour yield (Sisskin et al., 1982) . However, this anomaly was recently shown to be due to inefficient initiation of this species by the dose of DMBA used by Sisskin and colleagues and if the correct dose of DMBA, or a different initiator such as MNNG was used, then DBA/2 mice responded to promotion by TPA with a high tumour yield (Di Giovanni et al., 1984) as predicted from their hyperplastic response (Sisskin et al., 1982) . Furthermore, it has recently been shown that neonatal mice which are refractory to TPA-induced hyperplasia (Bertsch & Marks, 1974) are also refractory to stage I promotion by TPA (Furstenberger et al., 1985) and these refractory conditions subside in parallel as the adult pattern of epidermal differentiation appears (Furstenberger et al., 1985) . Stage I promotion has also been directly shown to require DNA synthesis (Kinzel et al., 1984a) . Taken together these studies indicate that epidermal hyperplasia or an event closely associated with it, is important for the completion of both stage I and stage II promotion, and this is supported by the work of Slaga et al. (1980a) who reported that steroids [potent inhibitors of epidermal hyperplasia (Belman & Troll, 1972; Scribner & Slaga, 1973; Schwarz et al., 1977) ] were potent inhibitors of both stage I and stage II promotion in SENCAR mice.
Epidermal hyperplasia is accompanied by increased synthesis of prostaglandins, enhanced ornthine decarboxylase and phosphodiesterase activities, refractoriness to catecholamines, desensitization to epidermal G1 chalone (for a review see Marks et al., 1982) and the appearance of morphologically distinct dark cells (Raick, 1973; Klein-Szanto et al., 1980) thought by some to be primitive stem cells. Of these changes the synthesis of prostaglandin E2 has been demonstrated to be crucial for the hyperplastic transformation of the epidermis as when its synthesis is blocked by inhibitors of cycloxygenase (Verma et al., 1980) or arachidonic acid metabolism (Fischer et al., 1982a) both hyperplasia (Verma et al., 1977; Furstenberger & Marks, 1978) , and tumour promotion (Slaga & Scribner, 1973; Verma et al., 1977; Fischer et al., 1982a) are prevented. Furthermore, the addition of exogenous prostaglandin E2 to skin where endogenous synthesis has been blocked results in a restoration of hyperplastic reponse (Verma et al., 1980; Furstenberger & Marks, 1978; Marks et al., 1981) though curiously not tumour promotion, the latter being partially restored by the addition of exogenous prostaglandin F2 which does not restore hyperplasia (Marks et al., 1982) . The latter authors have suggested that prostaglandin F2. may be involved in an event that is absolutely essential for promotion, whilst prostaglandin E2 mediated proliferation and hyperplasia play only a permissive role.
In line with this, whilst the above changes brought about by TPA are also brought about by certain kinds of epidermal injury such as wounding and full thickness abrasion which are also promoting stimuli (Hennings & Boutwell, 1970; Clark-Lewis & Murray, 1978; Argyris, 1980a) they are also produced by non-promoting stimuli such as mild abrasion by sandpaper rubbing (Marks et al., 1979) and treatment of the skin with the calcium ionophore, A23187 (Marks et al., 1981; KleinSzanto et al., 1982) . Similarly, with the exception of dark cell induction (Klein-Szanto et al., 1980 all the TPA-induced effects cited above are produced with at least equal potency by the second stage promoters mezerein (Mufson et al., 1979) and RPA (Furstenberger et al., 1981) .
This together with several other reports of nonpromoting hyperplasiogenic agents (Slaga et al., 1975; Raick & Burdzy, 1973; Raick, 1974; Hennings & Boutwell, 1970) might lead one to conclude as many have done, that hyperplasia and the biochemical changes associated with it are necessary but insufficient conditions for promotion (see for example, Slaga et al., 1975; Marks et al., 1979; Mufson et al., 1979) . It is therefore possible that there are subtle differences in the manner in which hyperplasia is brought about by some of these epidermal manipulations which could account for their being unable to promote tumour development. I shall argue the case for this in the next section.
4. TPA-induced keratinocyte terminal differentiation and the selection of initiated cells
There are now many reports that normal keratinocyte differentiation in vitro (Steinert & Yuspa, 1978; Yuspa et al., 1980 Yuspa et al., , 1982 Hawley-Nelson et al., 1982; Parkinson & Emmerson, 1982; Mufson et al., 1982 , Reiners & Slaga, 1983 and in vivo (Reiners & Slaga, 1983 ) is accelerated by TPA. As stated earlier (Section 2) colonies of keratinocytes which fail to respond to terminal differentiation signals can be detected in vitro following initiation of mouse skin in vivo. Furthermore, their numbers are increased following in vivo treatment with TPA (Yuspa & Morgan, 1981) . Although these putatively initiated cells also gave rise to immortal cell lines in vitro (Yuspa et al., 1983b) , it was suggested that the initiated cells grow into papillomas after TPA treatment because unlike normal keratinocytes they would be resistant to the induction of terminal differentiation by the tumour promoter and would clonally expand into the space left by the suprabasally migrating normal keratinocytes (Argyris, 1980b; 1983) during the regenerative hyperplasia that follows promoter treatment (Argyris, 1980b) .
In support of these arguments it has now been shown that cell lines derived from papillomas (Parkinson et al., 1984) , squamous cell carcinomas (Parkinson & Emmerson, 1982; Parkinson et al., 1983 Parkinson et al., , 1984 Stanley et al., 1985; Willey et al., 1984) keratinocytes transformed by viruses (Parkinson & Emmerson, 1982; Parkinson et al., 1983; Yuspa et al., 1985) and the progeny of putative initiated cells (Yuspa et al., 1983b; Hennings et al., 1984) are all refractory or less sensitive than normal to TPA-induced terminal differentiation. Furthermore, we have shown that a non-tumourigenic subclone of a skin carcinoma (cell line SCC-12F) which responds normally to the terminal differentiation stimulus of suspension culture (Rheinwald & Beckett, 1980) , also responds normally to TPA (Parkinson et al., 1983 (Parkinson et al., , 1984 showing that the defective response of transformed keratinocytes is indeed due to a defect in their ability to respond to terminal differentiation signals, and not to other transformation events such as in vitro immortalisation for example.
If the defect possessed by the initiated cells and their progeny enables them to selectively resist terminal differentiation by TPA, then no such selective resistance should be observed by non promoting hyperplasiogens such as the calcium ionophore, A23187 (Marks et al., 1981) or ethyl phenyl propiolate (Raick & Burdzy, 1973) . When we tested these compounds on normal and transformed keratinocytes in vitro we found that the transformed keratinocytes lost their ability to replicate (as assessed by loss of cloning ability) at least as much as their normal counterparts (Parkinson & Emmerson, 1984) and were in fact five times more sensitive to A23187. This lack of selectivity in favour of transformed keratinocytes may therefore explain the failure of certain hyperplasiogenic chemicals as promoters in vivo whilst others like acetic acid (Murray, 1978) and certain doses of mezerein (Sharkey cited by Argyris, 1983) may be so toxic that they kill the initiated cells before they are promoted.
If these explanations are true for the failure of certain hyperplasiogenic chemicals as promoters how does the selection theory fit for other types of epidermal manipulation? Why for example, does wounding (Hennings & Boutwell, 1970; Clark-Lewis & Murray, 1978) or deep abrasion (Argyris, 1980a) promote tumours whereas milder forms of epidermal manipulation (Clark-Lewis & Murray, 1978; Marks et al., 1979) do not. Marks et al. (1982) have introduced the concept that a 'woundspecific' response is crucial to tumour promotion by injury and by TPA and have suggested that the release of a 'wound-hormone' may be critical in the former instance. There is now evidence for the convergence of this idea with the selection theory of . A platelet-derived factor (Lechner et al., 1983) , recently characterised as TGF-,B (C.C. Harris, personal communication), stimulates differentiation and keratinization of normal, but not transformed human bronchial epithelial cells proliferating in a chemically defined medium, in a very similar manner to TPA (Willey et al., 1984) , and hence might be expected to permit the same type of selective advantage to the initiated cells and their progeny if released in chemically initiated skin. The reports that the effect of TGF-# is synergistic with EGF to promote wound repair , and that it is found in platelets (Childs et al., 1982; Assoian et al., 1983) and clotted blood serum (Childs et al., 1982) but not plasma (Childs et al., 1982) , suggest that the release of TGF-f may occur as part of the natural process of wound healing following damage to blood vessels. Blood vessel damage and the release of TGF-,B would accompany the promoting stimuli of skin wounding (Hennings & Boutwell, 1980; ClarkLewis & Murray, 1978; Marks et al., 1979) and to a lesser extent deep abrasion (Argyris, 1980a) , but not the non-promoting stimuli of superficial abrasion (Marks et al., 1979) or skin massage (Clark-Lewis & Murray, 1978; Marks et al., 1979) .
There is now good evidence that the membrane receptor for TPA (Delclos et al., 1980) is protein kinase C (Castagna et al., 1982) . Protein kinase C is normally activated by diacyglycerol which is produced by the stimulation of phosphatidyl inositol turnover following the interaction of certain hormones or growth factors with their receptors (see Nishizuka, 1984 , for a review). As there is evidence from other systems that the induction of differentiation by TPA may involve protein kinase C (Fuerstein & Cooper, 1984; Ebeling et al., 1985) it is also possible that other hormones and growth factors might be released during wounding to activate the enzyme and like TPA give the keratinocytes a selective advantage. The same argument applies to tumour promoters like teleocidin which bind to the phorbol ester receptor (Umezawa et al., 1981; Schmidt et al., 1983) .
However, epidermal tumour promoters like anthralin or benzoyl peroxide do not bind to phorbol ester receptors (Delclos et al., 1980) suggesting that their molecular mechanism of action is different from that of TPA. This is further substantiated by the observation that benzoyl peroxide is an efficient promoter in mouse strains where TPA is not (Reiners et al., 1984) . Anthralin and benzoyl peroxide do not produce the same morphological effects as TPA in keratinocyte cultures (Parkinson & Emmerson, 1982; Lawrence et al., 1984) but benzoyl peroxide is reported to induce cornification in other systems (Saladino et al., 1985) . Nevertheless, as the differential effect of these compounds on normal and transformed keratinocytes in vitro has not yet been examined the application of the selection theory 1983b) to non-phorbol promoters cannot be ruled out.
Diethylstilboestrol is a possible tumour promoter in the human genital tract (Lillehaug & Djurhuus, 1982; Siegfried et al., 1984) and when Stanley et al. (1985) studied its effects on cultured cervical keratinocytes and their transformed counterparts, the found it killed tumour cells rather more slowly than normal keratinocytes perhaps indicating that some non phorbol promoters are also selective for transformed cells. However this would be a weak effect compared to that produced by TPA .
Heterogeneity of the reponse of basal keratinocytes to TPA-induced terminal differentiation
It is thought that initiated cells have the phenotype of normal cells (Boutwell, 1974 (Boutwell, , 1982 or that their transformed character is greatly repressed (see Hennings & Yuspa, 1985, and references therein) . This coupled with the observation that initiation is essentially permanent suggests that initated cells are stem cells or committed cells that have irreversibly dedifferentiated into stem cells as a consequence of initiation, because under normal circumstances the stem cells are the only permanent residents of the epidermis (see Potten, 1983 , for a review). If initiated cells have a normal phenotype however, the simple version of the selection theory outlined in section 4 is presented with a problem. If TPA were to induce all phenotypically normal keratinocytes to differentiate with equal probability the first promoter treatment would result in the loss through terminal differentiation of many initiated cells before they could be promoted. Whilst this may be the case, it seems more likely that the loss of initiated cells is avoided because they are contained within a keratinocyte sub-population, which also contains the stem cells, and which is refractory or less sensitive to the induction of terminal differentiation by TPA (see .
Keratinocyte sub-populations have indeed been reported in which TPA fails to inhibit DNA synthesis and increase transglutaminase activity (Yuspa et al., 1982 (Yuspa et al., , 1983b or induce cornified envelope and disulphide bond formation (Reiners & Slaga 1983 ). Also we have found that when keratinocyte cultures are treated with various doses of TPA, a dose of 10 -8M is sufficient to eliminate the replicative potential of most of the keratinocytes, but a small sub-population is resistant to doses as high as 10-M (Parkinson et al., 1983; . These TPAR keratinocytes are the precursor population of the other clonogenic keratinocytes and their differentiated progeny (Parkinson et al., 1983) , and show an inverse relationship with the differentiated keratinocytes in a variety of experimental situations (see Parkinson et al., 1984) . Yuspa et al., (1982 Yuspa et al., ( , 1983b have also described a keratinocyte population which fails to respond to TPA-induced terminal differentiation and which regenerates the TPA-responsive population. We have suggested that the TPAR keratinocytes are a sub-population of clonogenic keratinocytes further removed from terminal differentiation than the rest (Parkinson et al., 1983; and Yuspa and coworkers have argued along similar lines (Yuspa et al., , 1982 (Yuspa et al., , 1983b (Argyris, 1980b; Reiners & Slaga, 1983) and with the observation that TPA induces a terminal differentiation in the majority of keratinocytes (Steinert & Yuspa, 1978; Yuspa et al., 1980; Parkinson & Emmerson, 1982; HawleyNelson et al., 1982; Mufson et al., 1982; Reiners & Slaga, 1983) . If treatment of the animals with TPA was delayed for one month to allow a study of the LRCs then these cells, the majority of which may be stem cells, responded very differently. They rarely moved suprabasally and divided at least once within the 28 h experimental period as evidenced by the appearance of labelled mitoses (Morris et al., 1985) . Furthermore, it was possible to demonstrate the persistance of some of the LRCs and their progeny for at least 2 weeks after TPA treatment suggesting that some of the LRCs were responsible for the long term regeneration of the epidermis following TPA-induced cell loss. If the LRCs are stem cells and the initiated keratinocytes are retained within this population then the induction of terminal differentiation in the mature basal keratinocytes coupled with the stimulation of stem cell division (including the initiated ones) would explain how essentially phenotypically normal initiated cells would at first expand into a clone 1983b) . Following this the transformed phenotype would be expressed (Slaga et al., 1980b; Furstenberger et al., 1983) and the transformed cells would be then given a selective advantage as outlined in section 4 (see Figure 2 ). Whether the stem cells (and hence also the initiated cells) are stimulated to divide directly by TPA as suggested by 1983b) or indirectly as a consequence of the natural response of the epidermal tissue to TPA-induced injury (Argyris, 1980b) is not entirely certain. The hypothesis of 1983b) predicts that because initiated cells are blocked at an early stage of differentiation (see also Yuspa et al., 1985) they should proliferate in reponse to TPA and remain refractory to the stimulus to differentiate. Recent studies have shown however, that whilst the second part of the prediction is fulfilled in cultured initiated cell lines, their proliferative response to TPA is variable (Hennings et al., 1984) . Regardless of the precise mechanism, the observation that epidermal proliferation follows TPA treatment of mouse skin in vivo, (Raick et al., 1972) is consistent with the selection theory proposed by Yuspa et al.
6. The selection theory and second stage promoters
At first because stage I of tumour promotion (see section 1) was thought to be irreversible and could be achieved by as little as one treatment with TPA (Slaga et al., 1980b; Furstenberger et al., 1983) , it was suggested that TPA caused 'a permanent alteration in the genetic readout of the initiated cell' to complete stage I whereas subsequent TPA treatments were only necessary to make the dormant papilloma cells become visible (Furstenberger et al., 1983) . However, the high efficiency by which a single TPA treatment achieves stage I promotion (40% of those initiated - Furstenberger et al., 1981) suggested that a permanent genomic change was unlikely to be involved, and recent data showing stage I of promotion to be reversible, with at most a half-life of 10 weeks (Slaga, 1983; Furstenberger & Marks, personal communication) , supports this suggestion. first introduced the concept that second stage promoters might be toxic to the initiated cells and have recently suggested that they might be operative at a later stage because the dose of the second stage promoter would most likely be reduced at later times as a result of the hyperplastic thickening of the epidermis. It was suggested that this, coupled with the increased initiated clone size, would afford protection against second-stage promoter toxicity (Hennings & Yuspa, 1985) . These authors further suggested that stage I promotion would be completed spontaneously by limited clonal expansion of the initiated cells so that a second-stage promoter (in this case, mezerein) would be efficient as a complete promoter if its application were delayed. They provided data which supported their hypothesis but their ideas are difficult to reconcile with the recent observation that stage I promotion is reversible even when brought about by TPA treatment (Slaga, 1983) whereas the clonal expansion following initiation is not (Loehrke et al., 1983) . However, the suggestion that second stage promoters may be more damaging to the initiated cells than TPA is supported by the observations that they inhibit tumour promotion by TPA when applied before it (Sharkey cited by Argyris, 1983) or together with it (Slaga et al., 1980b) . Furthermore, the TPAR population in keratinocyte cultures which is similar to the stem cell population in vivo as regards its response to TPA (and hence might be representative of the initiated cells -see section 5) is very sensitive to both mezerein and RPA (Parkinson et al., 1984; Stanley et al., 1985) . Similarly, preliminary reports suggest that the labelretaining putative stem cells (Mackenzie & Bickenbach, 1982) are not stimulated to divide by either mezerein (McCutcheon et al., 1984) or RPA (McCutcheon et al., 1985) in contrast to their stimulation by TPA (Morris et al., 1985) . Dark cells thought by some to primitive keratinocytes (Raick, 1973) are also observed in relatively fewer numbers in mezerein-treated, as opposed to TPA-treated Sencar mouse skin (Klein-Szanto et al., 1980; and there is evidence that dark cell induction is a good indicator of stage I promoting power in this system (Klein-Szanto et al., 1982; Slaga et al., 1980a) . The apparent toxic action of second stage promoters may result from their ability to induce terminal differentiation in all the basal cells equally whereas TPA appears to preferentially affect the more mature population (Parkinson et al., 1983; Morris et al., 1985) .
Nevertheless, the observations that RPA at the 10nmol dose-used by Furstenberger and coworkers (Furstenberger et al., 1981 (Furstenberger et al., , 1983 is not toxic to the initiated cells (Kinzel et al., 1984a) and that RPA is 10-fold less potent at inhibiting DNA synthesis in HeLa cells (Kinzel et al., 1984b) suggest that second-stage promoters fail as complete promoters because at low doses they do not fulfil a vital function necessary for the completion of stage I promotion, but that when the dose is increased to a level where stage I could be completed they are toxic to the initiated cells and so few papillomas still result (Parkinson et al., 1984) . Additional evidence that there are indeed two qualitatively different stages in promotion comes from the observations that the two stages are inhibited by different antagonists (Slaga et al., 1980a) and are dependent to different extents on the synthesis of prostaglandins F2a and E2 (Fustenberger & Marks, personal communication) . This suggests that the two stages have a different molecular basis. Furthermore, the argument that the second stage promoters fail to promote because they are generally toxic is also not supported by our observation that cell lines from papillomas and carcinomas respond to second stage promoters and TPA in a similar fashion (Parkinson et al., 1984; Stanley et al., 1985) . Additionally, transformed cell lines are sensitive to the toxic effects of the second stage promoters if the defective response to a differentiation signal is not expressed, as is the case with the non-tumourigenic subclone F of carcinoma line SCC-12 (Parkinson et al., 1984) .
Taken together the above data suggest that toxicity may play a part in the failure of RPA and mezerein to promote tumours but that full phenotypic expression of the defective response to inducers of terminal differentiation may also be associated with the early TPA treatments. Whilst a quasi-stable derepression of the initiated phenotype is consistent with this, stage I could also be explained by the selection hypothesis 1983b; see Figure 3 ).
The first TPA treatment of mouse skin causes inhibition of DNA synthesis (Raick et al., 1972) and extensive basal cell loss (Argyris, 1980b;  Figure 3 The role of selection in tumour promotion. Reiners & Slaga, 1983; Morris et al., 1985) probably as a consequence of induced terminal differentiation (see sections 3, 4 and 5). In the hyperplasia that follows, extensive regeneration of the epidermis would occur from the stem cell compartment (including the initiated cells) as discussed earlier (section 5), and could in some way release the initiated cell from the repressive effect of local inhibitory factors (Bell, 1976 (Marks et al., 1982) , where the basal layer is taken over by a chalone insensitiv9 stem cell population (Marks et al., 1978a, b) that is stimulated to proliferate by TPA instead of being inhibited 1983b , 1982) . Assuming that the above statements are true then it is clear that the first clonal expansion after TPA would be much larger than the subsequent ones as there would be far more basal cell loss in the former case, removing any lateral restriction to expansion of the initiated clones along the basement membrane. With later treatments the growth of the papilloma would be restricted to an upward direction because of the lateral restriction of the normal basal cells, explaining also the classic pedunculated shape of these lesions. Such an argument is also consistent with the observation that stage I of promotion is much longer lasting than stage II (Slaga et al., 1980b; Furstenberger et al., 1983) .
To summarise, I am suggesting that in contrast to TPA, second stage promoters are unable to cause the initial selective growth from the stem cell compartment, because they induce terminal differentiation in all the basal cells equally, unlike TPA which selectively induces differentiation in the more mature basal keratinocytes (Parkinson et al., 1983; Parkinson et al., 1984; Morris et al., 1985 (Parkinson et al., 1984) .
The role of selection in tumour promotion
It was recently shown that more than one oncogene must be activated in concert to malignantly transform fibroblasts (Ruley, 1983 , Land et al., 1983 , Newbold & Overell, 1983 . Initiated cells contain at least one of the genomic changes required for keratinocyte malignancy and the selective clonal expansion of these cells into papillomas of 105-106 cells (Hennings & Yuspa 1985) would increase the probability that one or more of the initiated cells will acquire the remaining changes required to complete carcinogenesis. Prior to malignancy papillomas may first acquire the ability to grow autonomously in the differentiating zone of the epidermis (see section 1, Figure  3 ) and there is some evidence that complementation of an activated rasH gene by immortalisation and/or aneuploidy (Weissman & Aaronson, 1983 ) allows keratincoytes to grow under conditions where ras1 activation alone cannot (Yuspa et al., 1983a (Yuspa et al., , 1985 . Cell lines cultured from papillomas also display both in vitro immortality (Pera & Gorman, 1984) and an activated rasH gene (M.F. Pera & A.
Balmain -personal communication). An increased ability to evade senescence when cultured in the presence of low levels of serum growth factors is a property associated with fibroblast immortality and in this cell type a combination of immortalisation and an activated rasH gene is sufficient to give malignancy (R.F. Newbold -personal communications). One could speculate that a reduced requirement for certain growth factors might also allow keratinocytes initiated by rasH activation to grow autonomously in zones of the epidermis where previously they could not (see Yuspa et al., 1985) . Whether the irreversible change from a promoterdependent to a promoter-independent lesion is spontaneous or whether it involves TPA-induced chromosome changes (Kinsella & Radman, 1978; Emeritt & Cerutti, 1981; Parry et al., 1981) or gene amplications (Varshavsky, 1981) as a possible consequence of the ability of TPA to generate free radicals (Troll et al., 1982) (Schwarz et al., 1984) and the effect of TPA on anchorage independence is blocked by both radical scavengers (Nakamura et al., 1985) and retinoids (Colburn, 1979 ) the last of which specifically inhibits stage II promotion (Slaga et al., 1980a) .
Nevertheless since cell lines derived from papillomas (unlike those from carcinomas) are still not tumourigenic (Pera & Gorman, 1984) it is clear that a third irreversible event is required to produce malignancy in keratinocytes in contrast to the situation with fibroblasts (Newbold & Overell, 1983) . This third event may only be necessary in epithelium because of the constraints placed upon the tumour cells by the close proximity of normal cells in this tissue as fully discussed elsewhere by Balmain (1985) , and in mouse skin carcinogenesis the evidence uniformily suggests that malignant conversion proceeds independently of TPA once the maximum papilloma yield has been obtained (Burns et al., 1978; Verma & Boutwell, 1980; Hennings et al., 1983) .
In this review I have attempted to present evidence supporting the hypothesis that clonal selection of the initiated cells ) is important for tumour promotion by TPA and wounding. It should be stressed however, that these ideas may not necessarily apply to promoters 6utside the diterpene series (Delclos et al., 1980; Reiners et al., 1984) or indeed to tissues other than those capable of cornification. A better assessment of the arguments put forward in this article will depend of course upon future developments in oncogene and growth factor research, but will also require an improvement in our knowledge of the keratinocyte cell lineage and in particular its response to injury. 
